Firalis - All Media

All Media

Launching the European Project VOLABIOS: A Breakthrough in Early Diagnosis and Monitoring of Schizophrenia

13.12.2024

Firalis Secures 1.284 M€ through France 2030 for New State-of-the-Art Bioproduction Facility in Huningue, France

26.11.2024

Amoneta Diagnostics obtains CE-marking certification under the IVDR for APO-Easy® Genotyping Kit

20.08.2024

Firalis Hosts Summer School for CombiDiag Doctoral Network in Huningue

02.07.2024

Amoneta Diagnostics and AD Data Initiative Announce ADDIA Data on AD Workbench

12.12.2023

Autoimmune project, PARADISE, holds first plenary to highlight six months of project progress

07.11.2023

COVIRNA Project Final Conference takes place on 19-April-23

COVIRNA Project end date is approaching, with the final conference that will take place in Brussels on the 19th of April, 2023.

07.04.2023

PARADISE Project launches with a kick-off held in Dublin (3-4 April 2023)

To develop a personalised prediction tool for better management of autoimmune diseases recurrence, PARADISE Project kicked off on 3 -4 April 2023 in Dublin, coordinated by ADAPT at Trinity College of Dublin, with partners across several European institutions, including FIRALIS.

05.04.2023